Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQPX1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,569
Award facts
- Contract value 100% obligated
- $49,569.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $49,569.45 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 100 unit vials. The delivery order, issued on December 10, 2025, with an ultimate completion date of January 2, 2026, was awarded without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supporting Department of Defense pharmaceutical supply needs worldwide.
DMS Pharmaceutical Group has been registered in the System for Award Management since July 2001 and maintains a single-award IDC (contract SPE2DR) under the PPV-G GEN V program with a $499.999 billion ceiling value and completion date of December 31, 2036. The contract structure includes a 30-month base period with three 30-month option periods, positioning the company as a critical supplier authorized to fulfill firm fixed-price delivery orders for branded and generic prescription drugs, biologics, vaccines, and medical consumables to support military healthcare operations. This BOTOX award exemplifies DMS Pharmaceutical Group's established performance in supplying specialized pharmaceutical products to federal military medical facilities.
Quick answers
Who was awarded contract SPE2DR26FQPX1?
SPE2DR26FQPX1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FQPX1 worth?
The government has obligated $49,569 on SPE2DR26FQPX1.
Is contract SPE2DR26FQPX1 an order under another contract?
Yes. SPE2DR26FQPX1 is a delivery order under SPE2DR25D9331, an indefinite delivery contract.
Was contract SPE2DR26FQPX1 competed?
The extent of competition for SPE2DR26FQPX1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award